New York Senate Bill S08866

New York 2025-2026 Regular Session

• Introduced: 1/12/26
• Refer: 1/12/26
• Engrossed: 1/27/26
• Refer: 1/27/26

Caption

Establishes "The Equity in Fertility Treatment Act"; relates to the definition of infertility and health insurance coverage for the treatment of infertility.

Summary

S08866, titled the "Equity in Fertility Treatment Act," amends New York insurance law to broaden the definition of infertility and expand health insurance coverage for in-vitro fertilization (IVF). The bill adds alternative pathways to qualify as infertile, including a person’s inability to reproduce as a single individual or with a partner without medical intervention, and allows a licensed physician or osteopathic physician to determine infertility based on medical, sexual, reproductive, age, physical, or diagnostic factors. It also clarifies that earlier evaluation and treatment may be appropriate based on an individual’s history and clinical findings. The bill changes coverage requirements for large group health insurance policies and contracts that already cover medical or major medical benefits. Instead of limiting coverage to three cycles of IVF, the bill requires coverage for three completed oocyte retrievals and unlimited embryo transfers from fresh or frozen oocytes or embryos from a covered retrieval, following American Society for Reproductive Medicine guidelines and using single embryo transfer when medically appropriate. It also bars insurers from denying coverage because a covered person participated in fertility services provided by or to a third party, while preserving the ability to apply deductibles, coinsurance, and copayments consistent with other benefits.

Impact

The bill would amend sections 3221 and 4303 of the Insurance Law, affecting large group health insurance policies and contracts issued in New York. It expands who may qualify for infertility treatment coverage and changes the structure of required IVF benefits, replacing a cycle-based limit with a retrieval-based framework and unlimited embryo transfers tied to a covered retrieval. The measure would directly affect insurers, employers offering large-group coverage, fertility clinics, and individuals seeking fertility treatment, and it would take effect immediately upon enactment.

Sentiment

The available voting history suggests generally favorable legislative sentiment toward the bill. It advanced unanimously in the Senate Rules Committee and then passed the Senate floor with a substantial majority, indicating broad support for expanding fertility treatment access. The bill text and title frame it as an equity measure, reflecting a policy goal of making fertility care more accessible and less restrictive.

Contention

The main points of contention appear to center on the scope and cost of mandated fertility coverage, particularly the expansion from three cycles to three completed oocyte retrievals with unlimited embryo transfers. Insurers and other cost-sensitive stakeholders may be concerned about increased utilization and premium impacts, while advocates are likely to support the broader infertility definition and the prohibition on denying coverage based on third-party fertility services. Another possible area of debate is the inclusion of single individuals and people whose infertility is determined through physician judgment rather than traditional conception-based criteria.